Pharmacists' Confidence in Managing Patients with Inflammatory Bowel Disease

Abstract

Background and aim: Managing patients with a chronic condition such as inflammatory bowel disease (IBD), requires a multidiscipline approach. The pharmacist might be the first point of contact for patients with initial symptoms or relapsing flares, yet there is no available literature on the role of pharmacists in IBD management. We conducted a survey to explore pharmacists' confidence in and potential barriers to managing IBD and assess the impact of IBD education on their confidence in IBD management. Methods: Surveys assessing confidence levels in managing IBD, additional learning opportunities about IBD and barriers to their learning of IBD management were provided to pharmacists for completion before and after attending an IBD-specific education session at a national conference. Results: Of the 195 attendees, 125 participants completed the survey (64%). Most respondents reported a low to mid-range level of confidence with managing IBD. Specifically, they were only slightly confident in decision making on patient care, addressing patient needs and providing additional support for IBD patients; and somewhat confident with understanding, management and providing relevant information on IBD. Whist the education session improved pharmacists perceived level of confidence, most respondents indicated a need to learn more about IBD. Areas of additional learning included science, drug therapy, treatments (includes non-pharmacological options as well) and guidelines. A majority of pharmacists identified time constraints as a key barrier to learning. Conclusion: Pharmacists lack sufficient confidence about managing inflammatory bowel disease. These data indicate support within the pharmacy profession to play a more active role in the management of IBD.

Keywords: continuing education; cross-sectional survey; inflammatory bowel disease; pharmacist; pharmacy practice; professional.

Figure 1

Overall confidence level of pharmacists pre- and post-inflammatory bowel disease (IBD) education session.

Figure 2

Confidence level of pharmacists for each statement in the pre-session (pre) compared to a parallel post-session statement (post). Pre-statement 1 = understanding IBD and management; post 1a = identifying signs and symptoms of IBD, post 1b = distinguishing IBD from other gastrointestinal diseases, post 1c = recognising when referral is required. Pre- and post-statement 2 = provide relevant information. Pre- and post-statement 3 = decision-making. Pre- and post-statement 4 = additional support. Pre- and post-statement 5 = address needs of patients.